ES2121782T3 - Composicion antineoplasica. - Google Patents

Composicion antineoplasica.

Info

Publication number
ES2121782T3
ES2121782T3 ES91908798T ES91908798T ES2121782T3 ES 2121782 T3 ES2121782 T3 ES 2121782T3 ES 91908798 T ES91908798 T ES 91908798T ES 91908798 T ES91908798 T ES 91908798T ES 2121782 T3 ES2121782 T3 ES 2121782T3
Authority
ES
Spain
Prior art keywords
antineoplastic composition
antineoplastic
composition
anthineoplastic
neoplasm
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES91908798T
Other languages
English (en)
Inventor
Kazuyoshi Kawai
Yasue Konishi
Satoru Nakai
Yoshikatsu Hirai
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Otsuka Pharmaceutical Co Ltd
Original Assignee
Otsuka Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Pharmaceutical Co Ltd filed Critical Otsuka Pharmaceutical Co Ltd
Application granted granted Critical
Publication of ES2121782T3 publication Critical patent/ES2121782T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/217—IFN-gamma
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

UN AGENTE ANTINEOPLASTICO CONTENIENDO INTERFERON-Y E INTERLEUCINA-1 COMO LOS INGREDIENTES ACTIVOS Y UN METODO PARA TRATAR CON ESTO EL NEOPLASMA.
ES91908798T 1990-05-09 1991-05-02 Composicion antineoplasica. Expired - Lifetime ES2121782T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2120557A JP2587711B2 (ja) 1990-05-09 1990-05-09 抗腫瘍剤

Publications (1)

Publication Number Publication Date
ES2121782T3 true ES2121782T3 (es) 1998-12-16

Family

ID=14789258

Family Applications (1)

Application Number Title Priority Date Filing Date
ES91908798T Expired - Lifetime ES2121782T3 (es) 1990-05-09 1991-05-02 Composicion antineoplasica.

Country Status (7)

Country Link
EP (1) EP0482213B1 (es)
JP (1) JP2587711B2 (es)
AU (1) AU644877B2 (es)
DE (1) DE69130099T2 (es)
DK (1) DK0482213T3 (es)
ES (1) ES2121782T3 (es)
WO (1) WO1991016916A1 (es)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8298523B2 (en) 2008-11-07 2012-10-30 United Technologies Ut Ag Compositions containing interleukin-1 and peptides

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2818834B2 (ja) * 1991-08-12 1998-10-30 大塚製薬株式会社 ＩＬ−１α安定化医薬製剤

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5995220A (ja) * 1982-11-22 1984-06-01 Ajinomoto Co Inc 免疫療法剤
EP0149551A3 (en) * 1984-01-16 1987-09-23 Genentech, Inc. Gamma interferon-interleukin-2 synergistic compositions and processes therefor
IL76591A0 (en) * 1984-10-05 1986-02-28 Bioferon Biochem Substanz Pharmaceutical compositions containing ifn-ypsilon and processes for the preparation thereof
JPS61277628A (ja) * 1985-06-04 1986-12-08 Asahi Chem Ind Co Ltd 癌治療用白血球刺激材
JPS61280432A (ja) * 1985-06-05 1986-12-11 Asahi Chem Ind Co Ltd 抗腫瘍免疫細胞誘導方法
JPS62265233A (ja) * 1986-04-03 1987-11-18 シタス　コ−ポレイシヨン インタ−フエロン−β及びインタ−ロイキン−２を含有する医薬組成物

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8298523B2 (en) 2008-11-07 2012-10-30 United Technologies Ut Ag Compositions containing interleukin-1 and peptides

Also Published As

Publication number Publication date
AU644877B2 (en) 1993-12-23
WO1991016916A1 (en) 1991-11-14
JP2587711B2 (ja) 1997-03-05
EP0482213A4 (en) 1993-03-17
JPH0418033A (ja) 1992-01-22
DE69130099D1 (de) 1998-10-08
DK0482213T3 (da) 1999-02-08
DE69130099T2 (de) 1999-02-18
EP0482213A1 (en) 1992-04-29
AU7757491A (en) 1991-11-27
EP0482213B1 (en) 1998-09-02

Similar Documents

Publication Publication Date Title
MX9202407A (es) Composicion farmaceutica que contiene un compuesto de alilamina como el agente activo y proceso para su preparacion.
DE19375061I2 (de) Hexadecylphosphocolin enthaltende arzneimittel mit antitumorwirkung.
MX9304975A (es) Una composicion en polvo para inhalacion y procedimiento para preparar la misma.
MX158449A (es) Composicion copolimerica acuosa,estable mejorada y procedimiento para su obtecion
MX9203279A (es) 1-aril-2-acilamido-3-fluoro-1-propanoles, metodos para su uso como agentes antibacterianos y composiciones utiles de los mismos.
ES531871A0 (es) Procedimiento para la fotorreticulacion mediante el uso de una composicion que contiene un material fotorreticulable y un aceptor de electrones.
SE7714066L (sv) Tillforselenhet for biologiskt aktiva emnen
ES504513A0 (es) Un procedimiento para la solubilizacion y estabilizacion de un agente antiparasitario.
AR240225A1 (es) Composicion insecticida que comprende mas de un compuesto activo.
ES8203375A1 (es) Procedimiento de preparar triazoloquinoxalin-4-onas substi- tuidas antihipertensoras
ES2076595T3 (es) Derivados de amidinofenilalanina, procedimiento para su preparacion, su empleo y agentes que los contienen.
NO774178L (no) Lagringsdyktig blanding som ved opploesning i vann gir en opploesning med antimikrobiell virkning
AR223372A1 (es) Procedimiento para obtener el compuesto antibiotico antitumoral bbm-928 que comprende los factores a,b,c,d,e y f
ES2121782T3 (es) Composicion antineoplasica.
ES2053535T3 (es) Derivados heterociclicos de cinco miembros de n,n'-diacilhidrazinas n' sustituidas.
AR229598A1 (es) Esteres 5-amino-1-fenilpirazol-4-carboxilicos,un procedimiento para la obtencion de los mismos y composiciones herbicidas que los contienen como agente activo
JPS5269909A (en) Water-in-oil emulsion fuel
IT8321137A0 (it) Composizioni catalitiche e per supporti cataliici.
AR229689A1 (es) Composicion fungicida,procedimiento para preparar el compuesto activo y dicho compuesto
ES516557A0 (es) Procedimiento para cargar un dispositivo anticonceptivo intrauuterino en el cilindro de un insertor.
NO985079L (no) Eksplosiv formulering
ES2043684T3 (es) 4-fluorofenil-1-(fluoroalcoxi-fenil-carbamoil)-pirazolinas sustituidas en posicion 3, con efecto insecticida.
ES265064Y (es) Losa para el suelo.
TR199700409T1 (xx) Harici kullan�ma mahsus enflamasyon �nleyici madde.
AR240169A1 (es) Carbazatos, procedimiento para su preparacion, un aditivo para pienso que los contiene y el procedimiento para su preparacion.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 482213

Country of ref document: ES